Back
Akero Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
AKRO
Akero Therapeutics
Last Price:
31.22
Seasonality Move:
5.92%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Akero Therapeutics Price Quote
$31.22
+0.58 (+1.91%)
(Updated: November 21, 2024 at 4:35 PM ET)
Akero Therapeutics Key Stats
Buy
61
Akero Therapeutics (AKRO)
is a Buy
Day range:
$29.88 - $31.60
52-week range:
$15.32 - $37.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.79%
Volume:
443.2K
Avg. volume:
608.9K
1-year change:
83.77%
Market cap:
$2.1B
Revenue:
$0
EPS:
$-3.78
How Much Does Akero Therapeutics Make?
Data Unavailable
Is Akero Therapeutics Growing As A Company?
Data Unavailable
Akero Therapeutics Stock Price Performance
-
Did Akero Therapeutics Stock Go Up Last Month?
Akero Therapeutics share price went down by -1.91% last month -
Did AKRO's Share Price Rise Over The Last Year?
AKRO share price rose by 83.77% over the past 1 year
What Is Akero Therapeutics 52-Week High & Low?
-
What Is Akero Therapeutics’s 52-Week High Share Price?
Akero Therapeutics has traded as high as $37.00 over the past 52 weeks -
What Is Akero Therapeutics’s 52-Week Low Share Price?
Akero Therapeutics has traded as low as $15.32 over the past 52 weeks
Akero Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Akero Therapeutics?
-
How Much Debt Does Akero Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Akero Therapeutics Have?
Cash and short term investments quarterly total is $717.2M -
What Is Akero Therapeutics’s Book Value Per Share?
Book value per share is 10.61
Is Akero Therapeutics Cash Flow Positive?
-
What Is AKRO Cash Flow From Operations?
Cash flow from operations (TTM) is -$211.6M -
What Is Akero Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $370.4M -
What Is Akero Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$112.2M
Akero Therapeutics Return On Invested Capital
Data Unavailable
Akero Therapeutics Earnings Date & Stock Price
-
What Is Akero Therapeutics's Stock Price Today?
A single share of AKRO can be purchased today for 30.64 -
What Is Akero Therapeutics’s Stock Symbol?
Akero Therapeutics trades on the nasdaq under the ticker symbol: AKRO -
When Is Akero Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Akero Therapeutics is scheduled on February 28, 2025 -
When Is AKRO's next ex-dividend date?
Akero Therapeutics's next ex-dividend date is May 26, 2020 -
How To Buy Akero Therapeutics Stock?
You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Akero Therapeutics Competitors
-
Who Are Akero Therapeutics's Competitors?
Below is a list of companies who compete with Akero Therapeutics or are related in some way:
Akero Therapeutics Dividend Yield
-
What Is AKRO Dividend Yield?
Akero Therapeutics’s dividend yield currently is 0% -
What Is Akero Therapeutics’s Payout Ratio?
Akero Therapeutics’s payout ratio is 0% -
When Did Akero Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Akero Therapeutics’s Dividend Per Share?
Akero Therapeutics pays a dividend of $0.00 per share
Akero Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -12.36% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 48.27 |
| Upside from Last Price: | 57.57% |